Portage Biotech Inc Cash Flow-to-Debt Ratio
Portage Biotech Inc cash flow-to-debt ratio. Portage Biotech Inc (PRTG) has a Cash Flow-to-Debt Ratio of -0.78x as of September 2024, meaning its operating cash flow of $-1.56 Million could theoretically repay -1% of its total liabilities ($2.01 Million) in one year. Check PRTG cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Portage Biotech Inc (1998–2025)
Cash flow-to-debt ratio of Portage Biotech Inc from 1998 to 2025. Historical debt coverage capacity for Portage Biotech Inc across 27 annual periods. Check Portage Biotech Inc (PRTG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Portage Biotech Inc Cash Flow-to-Debt Ratio by Year (1998–2025)
Portage Biotech Inc cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Portage Biotech Inc. For the full cash flow conversion analysis, see Portage Biotech Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $4.45 Million | ▼ -531.6% |
| 2023 | -0.51x | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $29.23 Million | ▼ -47.2% |
| 2021 | -0.16x | $-4.28 Million | $27.26 Million | ▼ -16.5% |
| 2020 | -0.13x | $-3.71 Million | $27.53 Million | ▼ -295.5% |
| 2019 | -0.03x | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $309.43K | ▲ +78.1% |
| 2016 | -19.48x | $-5.84 Million | $299.74K | ▼ -362.5% |
| 2015 | -4.21x | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $191.97K | ▼ -151.5% |
| 2013 | -4.01x | $-1.79 Million | $446.87K | ▼ -696.4% |
| 2012 | -0.50x | $-1.34 Million | $2.66 Million | ▲ +86.9% |
| 2011 | -3.84x | $-2.62 Million | $682.75K | ▼ -3626.2% |
| 2010 | -0.10x | $-356.14K | $3.45 Million | ▲ +95.7% |
| 2009 | -2.39x | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.18x | $-468.92K | $57.34K | ▲ +25.1% |
| 2007 | -10.93x | $-458.84K | $42.00K | ▼ -139.5% |
| 2006 | -4.56x | $-645.50K | $141.52K | ▼ -837.2% |
| 2004 | -0.49x | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $233.80K | ▲ +49.3% |
| 2002 | -1.24x | $-156.80K | $126.48K | ▲ +66.2% |
| 2001 | -3.67x | $-347.00K | $94.62K | ▼ -19.1% |
| 2000 | -3.08x | $-466.90K | $151.67K | ▲ +41.9% |
| 1999 | -5.30x | $-345.09K | $65.14K | ▼ -522.1% |
| 1998 | -0.85x | $-422.97K | $496.67K | — |